Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients

被引:11
作者
Atageldiyeva, Kuralay K. [1 ]
Nemr, Rita [2 ]
Echtay, Akram [3 ]
Racoubian, Eddie [4 ]
Sarray, Sameh [5 ,6 ]
Almawi, Wassim Y. [1 ,6 ]
机构
[1] Nazarbayev Univ Astana, Sch Med, Astana, Kazakhstan
[2] Rizk Hosp, LAU Med Ctr, Dept Internal Med, Beirut, Lebanon
[3] Rafic Henri Univ Hosp, Dept Adult Endocrinol & Diabet, Beirut, Lebanon
[4] St Marc Med Ctr, Beirut, Lebanon
[5] Arabian Gulf Univ, Coll Med & Med Sci, Manama, Bahrain
[6] El Manar Univ, Fac Sci, Tunis, Tunisia
关键词
Apolipoprotein E; Diabetic nephropathy; Genotyping; Type 2 diabetes mellitus; E EPSILON-4 ALLELE; ALZHEIMERS-DISEASE; ASSOCIATION; APOE; LEBANESE; LIPOPROTEINS; ALBUMINURIA; POPULATIONS; FREQUENCY; VARIANTS;
D O I
10.1016/j.gene.2019.144011
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: An association between Apolipoprotein E (Apo E) alleles and genotypes and diabetic nephropathy (DN) was suggested, but with inconsistent results. We tested the relationship between serum lipids, Apo E alleles and genotypes with type 2 diabetes (T2DM), and DN pathogenesis. Methods: Study subjects comprised 1389 normoglycemic controls, and 1422 T2DM patients, of whom 825 were normoalbuminuric (DWN), and 597 presented with nephropathy (DN). Results: Significantly lower Apo epsilon 2, and higher Apo epsilon 4 allele frequencies was seen among T2DM patients than controls. Significantly higher frequency of epsilon 3/epsilon 4, and lower frequencies of epsilon 3/epsilon 3, epsilon 2/epsilon 3, and epsilon 4/epsilon 4 carriers was seen among T2DM cases. Apo epsilon 2-carrying individuals were more frequently found in controls than in patients, while significantly higher frequency of epsilon 4-carrying genotypes was seen in T2DM cases. Significantly higher epsilon 2, and lower epsilon 3 allele frequencies were noted for DN group compared to DWN group. Significantly higher frequency of epsilon 2-containing epsilon 2/epsilon 3 and epsilon 2/epsilon 4, and lower frequencies of epsilon 3/epsilon 3 carriers was seen among DN cases. Apo epsilon 3/epsilon 3 was associated with higher total cholesterol, LDL-cholesterol, and triglyceride levels in DN patients, and significantly higher triglyceride levels were seen in epsilon 2/epsilon 3-carrying DN patients. Logistic regression analysis confirmed the association of Apo epsilon 3-containing epsilon 3/epsilon 3, epsilon 2/epsilon 3, and epsilon 3/epsilon 4, and Apo epsilon 2-containing epsilon 2/epsilon 4 with DN, after controlling for key covariates. Conclusion: The results of this case-control study provide evidence that the epsilon 2 and epsilon 3 alleles of APOE modify lipid profile, and constitute independent risk factors of DN in type 2 diabetes. The molecular mechanisms underlying this risk is discussed.
引用
收藏
页数:7
相关论文
共 53 条
[1]   Apolipoprotein E polymorphism in a healthy Lebanese population [J].
Almawi, WY ;
Hassan, GS ;
Habbal, MZ .
MEDICAL PRINCIPLES AND PRACTICE, 1999, 8 (02) :105-110
[2]   APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes -: Results of case-control and family-based studies [J].
Araki, S ;
Moczulski, DK ;
Hanna, L ;
Scott, LJ ;
Warram, JH ;
Krolewski, AS .
DIABETES, 2000, 49 (12) :2190-2195
[3]   A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS [J].
Arar, Nedal H. ;
Voruganti, Venkata S. ;
Nath, Subrata D. ;
Thameem, Farook ;
Bauer, Richard ;
Cole, Shelley A. ;
Blangero, John ;
MacCluer, Jean W. ;
Comuzzie, Anthony G. ;
Abboud, Hanna E. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (10) :3184-3191
[4]   Apolipoprotein E genotyping in Egyptian diabetic nephropathy patients [J].
Atta, Mohamed I. ;
Gabal, Khadiga Abo ;
El-Hadidi, Khalid ;
Swellam, Menha ;
Genina, Ashraf ;
Zaher, Nabil F. .
IUBMB LIFE, 2016, 68 (01) :58-64
[5]   Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease [J].
Bahri, Raoudha ;
Esteban, Esther ;
Moral, Pedro ;
Hassine, Mohsen ;
Ben Hamda, Khaldoun ;
Chaabani, Hassen .
LIPIDS IN HEALTH AND DISEASE, 2008, 7 (1)
[6]   Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease [J].
Barbagallo, CM ;
Rizzo, M ;
Noto, D ;
Frasheri, A ;
Pernice, V ;
Rubino, A ;
Pieri, D ;
Pinto, V ;
Cefalù, AB ;
Giordano, C ;
Notarbartolo, A ;
Averna, MR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (05) :662-668
[7]   ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM? [J].
Boize, R ;
Benhamou, PY ;
Corticelli, P ;
Valenti, K ;
Bosson, JL ;
Halimi, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (01) :72-75
[8]   Association study of genetic variants of 17 diabetes-related genes/loci and cardiovascular risk and diabetic nephropathy in the Chinese She population [J].
Chen, Gang ;
Xu, Yuan ;
Lin, Yinghua ;
Lai, Xiaolan ;
Yao, Jin ;
Huang, Baoying ;
Chen, Zichun ;
Huang, Huibin ;
Fu, Xianguo ;
Lin, Lixiang ;
Lai, Shenghan ;
Wen, Junping .
JOURNAL OF DIABETES, 2013, 5 (02) :136-145
[9]   Risk factors in metabolic syndrome predict the progression of diabetic nephropathy in patients with type 2 diabetes [J].
Chuang, Shih-Ming ;
Shih, Hong-Mou ;
Chien, Ming-Nan ;
Liu, Sun-Chen ;
Wang, Chao-Hung ;
Lee, Chun-Chuan .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 153 :6-13
[10]   Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort [J].
de Boer, Ian H. ;
Rue, Tessa C. ;
Cleary, Patricia A. ;
Lachin, John M. ;
Molitch, Mark E. ;
Steffes, Michael W. ;
Sun, Wanjie ;
Zinman, Bernard ;
Brunzell, John D. .
ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) :412-420